Efficacy of a bivalent vaccine against Marek's disease.
A bivalent vaccine was prepared by combining inactivated Marek's disease virus and turkey herpesvirus. The efficacy of this vaccine, compared to turkey herpesvirus and inactivated Marek's disease virus separately, was studied in unsexed White Leghorn chicks which were vaccinated at one day old and then challenged at 21 days old with fowl blood infected with virulent Marek's disease virus. The bivalent vaccine appreciably delayed mortality resulting from Marek's disease and elicited the highest protective efficacy as judged on the basis of Marek's disease-specific mortality and percentage occurrence of lesions. The occurrence, extent and severity of gross lymphomas and microscopic lymphoproliferative lesions in various organs of the bivalent vaccinated birds were less than in the other challenged groups. In addition, the level of viraemia remained consistently and significantly lower in the bivalent vaccinated birds.
D000818:Animals; D002642:Chick Embryo; D002645:Chickens; D004338:Drug Combinations; D006564:Herpesviridae / Q000276:immunology*; D008381:Herpesvirus 2, Gallid / Q000276:immunology*; D008380:Marek Disease / Q000517:prevention & control*; D011897:Random Allocation; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D014766:Viremia / Q000517:prevention & control / Q000662:veterinary
D004338:Drug Combinations; D014613:Vaccines, Attenuated; D014765:Viral Vaccines